Sichuan Goldstone Asia Pharmaceutical Management
Management criteria checks 1/4
We currently do not have sufficient information about the CEO.
Key information
Yiping Ma
Chief executive officer
n/a
Total compensation
| CEO salary percentage | n/a |
| CEO tenure | 1.1yrs |
| CEO ownership | n/a |
| Management average tenure | 1.1yrs |
| Board average tenure | 4.2yrs |
Recent management updates
Recent updates
Sichuan Goldstone Asia Pharmaceutical's (SZSE:300434) Conservative Accounting Might Explain Soft Earnings
Nov 02
There's Reason For Concern Over Sichuan Goldstone Asia Pharmaceutical Inc.'s (SZSE:300434) Massive 42% Price Jump
Oct 08Sichuan Goldstone Asia Pharmaceutical (SZSE:300434) Has A Pretty Healthy Balance Sheet
Sep 30Sichuan Goldstone Asia Pharmaceutical's (SZSE:300434) Conservative Accounting Might Explain Soft Earnings
May 02CEO
Yiping Ma (53 yo)
1.1yrs
Tenure
Mr. Yiping Ma is Chairman and General Manager of Sichuan Goldstone Asia Pharmaceutical Inc. from December 22, 2023.
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Chairman & GM | 1.1yrs | no data | no data | |
| CFO & Accounting Supervisor | 2.1yrs | CN¥803.70k | no data | |
| Deputy GM | no data | CN¥665.70k | 1.56% CN¥ 52.4m | |
| Deputy GM & Director | 1.1yrs | no data | no data | |
| Deputy General Manager | no data | CN¥2.93m | 0.071% CN¥ 2.4m |
1.1yrs
Average Tenure
50yo
Average Age
Experienced Management: 300434's management team is not considered experienced ( 1.1 years average tenure), which suggests a new team.
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Chairman & GM | 1.1yrs | no data | no data | |
| Deputy GM | 13.6yrs | CN¥665.70k | 1.56% CN¥ 52.4m | |
| Deputy GM & Director | 4.2yrs | no data | no data | |
| Independent Director | 1.1yrs | no data | no data | |
| Vice Chairman | 4.2yrs | CN¥506.00k | 13.59% CN¥ 456.8m | |
| Vice Chairman | 7.3yrs | CN¥1.00m | 3.64% CN¥ 122.5m | |
| Non-Independent Director | 7.3yrs | no data | 0.92% CN¥ 31.0m | |
| Non-Independent Director | 7.3yrs | CN¥1.05m | no data | |
| Chairman of Supervisory Board | 4.2yrs | no data | no data | |
| Independent Director | 1.1yrs | no data | no data | |
| Independent Director | 1.1yrs | no data | no data | |
| Independent Director | 1.1yrs | no data | no data |
4.2yrs
Average Tenure
56.5yo
Average Age
Experienced Board: 300434's board of directors are considered experienced (4.2 years average tenure).
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/01/24 20:30 |
| End of Day Share Price | 2025/01/24 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Sichuan Goldstone Asia Pharmaceutical Inc. is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|